1. Home
  2. EVOK vs VCIG Comparison

EVOK vs VCIG Comparison

Compare EVOK & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • VCIG
  • Stock Information
  • Founded
  • EVOK 2007
  • VCIG 2013
  • Country
  • EVOK United States
  • VCIG Malaysia
  • Employees
  • EVOK N/A
  • VCIG N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • VCIG Diversified Commercial Services
  • Sector
  • EVOK Health Care
  • VCIG Consumer Discretionary
  • Exchange
  • EVOK Nasdaq
  • VCIG Nasdaq
  • Market Cap
  • EVOK 7.0M
  • VCIG 5.8M
  • IPO Year
  • EVOK 2013
  • VCIG 2023
  • Fundamental
  • Price
  • EVOK $4.96
  • VCIG $1.70
  • Analyst Decision
  • EVOK
  • VCIG
  • Analyst Count
  • EVOK 0
  • VCIG 0
  • Target Price
  • EVOK N/A
  • VCIG N/A
  • AVG Volume (30 Days)
  • EVOK 38.4K
  • VCIG 19.9M
  • Earning Date
  • EVOK 11-07-2024
  • VCIG 02-10-2025
  • Dividend Yield
  • EVOK N/A
  • VCIG N/A
  • EPS Growth
  • EVOK N/A
  • VCIG N/A
  • EPS
  • EVOK N/A
  • VCIG 7.82
  • Revenue
  • EVOK $8,617,036.00
  • VCIG $23,548,256.00
  • Revenue This Year
  • EVOK $97.35
  • VCIG N/A
  • Revenue Next Year
  • EVOK $99.52
  • VCIG N/A
  • P/E Ratio
  • EVOK N/A
  • VCIG $0.21
  • Revenue Growth
  • EVOK 100.35
  • VCIG 89.38
  • 52 Week Low
  • EVOK $3.54
  • VCIG $1.38
  • 52 Week High
  • EVOK $14.04
  • VCIG $115.15
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 54.79
  • VCIG 41.95
  • Support Level
  • EVOK $4.33
  • VCIG $1.44
  • Resistance Level
  • EVOK $5.75
  • VCIG $1.66
  • Average True Range (ATR)
  • EVOK 0.39
  • VCIG 0.34
  • MACD
  • EVOK 0.13
  • VCIG 0.02
  • Stochastic Oscillator
  • EVOK 54.34
  • VCIG 11.62

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About VCIG VCI Global Limited

VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development solution consultancy. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology Consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment which focuses on listing solutions, investor relations, and boardroom strategies consultancy. It has established a diverse local and international clientele, providing them with its services in both local and cross-border listings. Its role begins with pre-listing diagnosis and planning to the finalization of the entire listing process.

Share on Social Networks: